CAREFUSION CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 40 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-12-15: Reporting owner Leonard Thomas J; Form 4; Security Stock Options (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-11-12: Reporting owner LOSH J MICHAEL; Form 4; Security Stock Options (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-10-15: Reporting owner OHALLERAN MICHAEL D; Form 4; Security Stock Options (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-10-15: Reporting owner OHALLERAN MICHAEL D; Form 4; Security Stock Options (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-12-15 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 24,163 owned after | $22.59 exercise price | 2014-12-17 | |
| 2014-11-12 | LOSH J MICHAEL Director | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,630 0 owned after | $22.35 exercise price | 2014-11-14 | |
| 2014-10-15 | OHALLERAN MICHAEL D Director | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,806 0 owned after | $34.36 exercise price | 2014-10-17 | |
| 2014-10-15 | OHALLERAN MICHAEL D Director | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,522 0 owned after | $30.80 exercise price | 2014-10-17 | |
| 2014-10-15 | OHALLERAN MICHAEL D Director | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,200 0 owned after | $30.80 exercise price | 2014-10-17 | |
| 2014-10-07 | LOSH J MICHAEL Director | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,806 0 owned after | $34.36 exercise price | 2014-10-08 | |
| 2014-10-06 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,400 49,163 owned after | $22.59 exercise price | 2014-10-08 | |
| 2014-10-06 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 1,764 owned after | $20.71 exercise price | 2014-10-08 | |
| 2014-10-01 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 21,764 owned after | $20.71 exercise price | 2014-10-03 | |
| 2014-09-19 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,141 0 owned after | $20.71 exercise price | 2014-09-22 | |
| 2014-09-19 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,459 57,563 owned after | $22.59 exercise price | 2014-09-22 | |
| 2014-09-15 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 4,141 owned after | $20.71 exercise price | 2014-09-16 | |
| 2014-08-15 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +57,439 57,439 owned after | $43.97 exercise price | 2014-08-19 | |
| 2014-08-15 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,372 11,372 owned after | $43.97 exercise price | 2014-08-19 | |
| 2014-08-15 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,787 80,787 owned after | $43.97 exercise price | 2014-08-19 | |
| 2014-08-15 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +33,372 33,372 owned after | $43.97 exercise price | 2014-08-19 | |
| 2014-08-15 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +117,375 117,375 owned after | $43.97 exercise price | 2014-08-19 | |
| 2014-08-15 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +350,997 350,997 owned after | $43.97 exercise price | 2014-08-19 | |
| 2014-08-15 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,027 30,027 owned after | $43.97 exercise price | 2014-08-19 | |
| 2014-08-15 | Paolucci Michael E Officer (EVP, Human Resources) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,249 56,249 owned after | $43.97 exercise price | 2014-08-19 | |
| 2014-07-01 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,798 0 owned after | $29.25 exercise price | 2014-07-03 | |
| 2014-07-01 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,923 0 owned after | $31.90 exercise price | 2014-07-03 | |
| 2014-06-19 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −494 41,764 owned after | $20.71 exercise price | 2014-06-20 | |
| 2014-06-09 | MARCHETTI ROGER Officer (EVP, Human Resources) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −29,750 14,876 owned after | $25.56 exercise price | 2014-06-11 | |
| 2014-06-09 | MARCHETTI ROGER Officer (EVP, Human Resources) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,643 33,288 owned after | $26.79 exercise price | 2014-06-11 | |
| 2014-06-06 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −400 42,258 owned after | $20.71 exercise price | 2014-06-06 | |
| 2014-06-05 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21,106 42,658 owned after | $20.71 exercise price | 2014-06-06 | |
| 2014-05-20 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −100,000 533,110 owned after | $27.84 exercise price | 2014-05-20 | |
| 2014-05-19 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,850 0 owned after | $20.71 exercise price | 2014-05-20 | |
| 2014-05-19 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 29,141 owned after | $20.71 exercise price | 2014-05-20 | |
| 2014-05-19 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,144 0 owned after | $25.09 exercise price | 2014-05-20 | |
| 2014-05-19 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,014 0 owned after | $31.90 exercise price | 2014-05-20 | |
| 2014-05-19 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,380 10,378 owned after | $20.71 exercise price | 2014-05-20 | |
| 2014-05-19 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,200 19,765 owned after | $22.59 exercise price | 2014-05-20 | |
| 2014-05-16 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,783 14,850 owned after | $20.71 exercise price | 2014-05-20 | |
| 2014-05-07 | FRANCIS PHILIP L Director | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,806 0 owned after | $34.36 exercise price | 2014-05-08 | |
| 2014-04-04 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,076 0 owned after | $31.90 exercise price | 2014-04-08 | |
| 2014-03-07 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −365 0 owned after | $17.77 exercise price | 2014-03-11 | |
| 2014-03-07 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 10,076 owned after | $31.90 exercise price | 2014-03-11 | |
| 2014-02-19 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Stock Options (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,213 0 owned after | $31.90 exercise price | 2014-02-21 |